Applied DNA Sciences (APDN) announced that Applied DNA Clinical Labs is repositioning its TR8 PGx pharmacogenomics testing service to offer ...

Applied DNA Sciences shares are trading higher by 18.7% during Tuesday's session. The company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety.

Corient Private Wealth LLC boosted its position in shares of Invesco Preferred ETF (NYSEARCA:PGX – Free Report) by 37.0% in ...

HighTower Advisors LLC boosted its stake in Invesco Preferred ETF (NYSEARCA:PGX – Free Report) by 87.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The ...

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...

Fintel reports that on March 28, 2025, B of A Securities downgraded their outlook for Voya Financial, Inc. - Preferred Stock ...

Dr. Abdullah Al Maruf, Assistant Professor, College of Pharmacy, University of Manitoba, is leading the PGX-SIMBA study.

Fintel reports that on March 28, 2025, BMO Capital upgraded their outlook for Hudson Pacific Properties, Inc. - Preferred ...

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...

Detailed price information for Preferred Invesco ETF (PGX-A) from The Globe and Mail including charting and trades.

Prosper Gold Corp. ("Prosper Gold" or the "Company") (TSXV: PGX) is pleased to announce a non-brokered private placement financing (the “Financing”) ...